Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: May 23, 2024
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA dermatology
Published: September 16, 2020
Defect evaluation by infant photographs in a multicenter pharmaceutical clinical trial.
Journal: Birth defects research
Published: August 30, 2019
The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.
Journal: Expert opinion on investigational drugs
Published: July 06, 2019
Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial.
Journal: Journal of the American Academy of Dermatology
Published: April 13, 2019
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: May 31, 2018
Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Journal: Human reproduction (Oxford, England)
Published: May 22, 2018
Pilot study of high-performance air filtration for classroom applications.
Journal: Indoor air
Published: May 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026